181 related articles for article (PubMed ID: 35969157)
1. Selective Inhibitors of Medium-Size S1' Pocket Matrix Metalloproteinases: A Stepping Stone of Future Drug Discovery.
Baidya SK; Banerjee S; Adhikari N; Jha T
J Med Chem; 2022 Aug; 65(16):10709-10754. PubMed ID: 35969157
[TBL] [Abstract][Full Text] [Related]
2. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX
J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275
[TBL] [Abstract][Full Text] [Related]
3. Understanding the variability of the S1' pocket to improve matrix metalloproteinase inhibitor selectivity profiles.
Gimeno A; Beltrán-Debón R; Mulero M; Pujadas G; Garcia-Vallvé S
Drug Discov Today; 2020 Jan; 25(1):38-57. PubMed ID: 31513929
[TBL] [Abstract][Full Text] [Related]
4. Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.
Fabre B; Ramos A; de Pascual-Teresa B
J Med Chem; 2014 Dec; 57(24):10205-19. PubMed ID: 25265401
[TBL] [Abstract][Full Text] [Related]
5. Specificity of binding with matrix metalloproteinases.
Gupta SP; Patil VM
Exp Suppl; 2012; 103():35-56. PubMed ID: 22642189
[TBL] [Abstract][Full Text] [Related]
6. Arylsulfonamides and selectivity of matrix metalloproteinase-2: An overview.
Adhikari N; Mukherjee A; Saha A; Jha T
Eur J Med Chem; 2017 Mar; 129():72-109. PubMed ID: 28219048
[TBL] [Abstract][Full Text] [Related]
7. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
[TBL] [Abstract][Full Text] [Related]
8. An updated patent review of matrix metalloproteinase (MMP) inhibitors (2021-present).
Banerjee S; Baidya SK; Adhikari N; Jha T
Expert Opin Ther Pat; 2023 Oct; 33(10):631-649. PubMed ID: 37982191
[TBL] [Abstract][Full Text] [Related]
9. Biomolecular basis of matrix metallo proteinase-9 activity.
Swetha R; Gayen C; Kumar D; Singh TD; Modi G; Singh SK
Future Med Chem; 2018 May; 10(9):1093-1112. PubMed ID: 29676173
[TBL] [Abstract][Full Text] [Related]
10. Molecular Dynamics Simulations of Matrix Metalloproteinase 13 and the Analysis of the Specificity Loop and the S1'-Site.
Choi JY; Chung E
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445757
[TBL] [Abstract][Full Text] [Related]
11. Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments.
Lin H; Xu P; Huang M
Future Med Chem; 2022 Jan; 14(1):35-51. PubMed ID: 34779649
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase inhibitors (MMPIs) as attractive therapeutic targets: Recent progress and current challenges.
Shi Y; Ma X; Fang G; Tian X; Ge C
NanoImpact; 2021 Jan; 21():100293. PubMed ID: 35559782
[TBL] [Abstract][Full Text] [Related]
13. Probing the S1' site for the identification of non-zinc-binding MMP-2 inhibitors.
Di Pizio A; Laghezza A; Tortorella P; Agamennone M
ChemMedChem; 2013 Sep; 8(9):1475-82, 1421. PubMed ID: 23873724
[TBL] [Abstract][Full Text] [Related]
14. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects.
Li W; Saji S; Sato F; Noda M; Toi M
Int J Biol Markers; 2013 Jun; 28(2):117-30. PubMed ID: 23787494
[TBL] [Abstract][Full Text] [Related]
15. Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations.
Mude L; Jupudi S; Swaroop AK; Tallapaneni V; Karri VVSR
J Biomol Struct Dyn; 2024 Mar; 42(5):2437-2448. PubMed ID: 37160705
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Phenolic Matrix Metalloproteinase Inhibitors by Peptide Microarray for Osteosarcoma Treatment.
Jian M; Sun X; Cheng G; Zhang H; Li X; Song F; Liu Z; Wang Z
J Nat Prod; 2022 Oct; 85(10):2424-2432. PubMed ID: 36122348
[TBL] [Abstract][Full Text] [Related]
17. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation.
Gentile E; Liuzzi GM
Drug Discov Today; 2017 Feb; 22(2):299-313. PubMed ID: 27697495
[TBL] [Abstract][Full Text] [Related]
18. Bioactives from Marine Organisms and their Potential Role as Matrix Metalloproteinase Inhibitors.
Thomas NV; Monica Diyya AS; Kim SK; Faraj KA; Ghafoor DD; Qian ZJ; Tigabu BM
Curr Pharm Des; 2022; 28(41):3351-3362. PubMed ID: 36411577
[TBL] [Abstract][Full Text] [Related]
19. Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke RE; Libert C
Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
[TBL] [Abstract][Full Text] [Related]
20. Design and Structural Evolution of Matrix Metalloproteinase Inhibitors.
Fischer T; Senn N; Riedl R
Chemistry; 2019 Jun; 25(34):7960-7980. PubMed ID: 30720221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]